1.89Open1.89Pre Close0 Volume38 Open Interest2.00Strike Price0.00Turnover415.88%IV2.64%PremiumAug 16, 2024Expiry Date1.79Intrinsic Value100Multiplier25DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type0.8717Delta0.0506Gamma1.67Leverage Ratio-0.0175Theta0.0007Rho1.45Eff Leverage0.0021Vega
CureVac Stock Discussion
Benzinga· 1 min ago
New trial date for U.S. patent litigation set for March 3, 2025, following settlement with Acuitas Therapeutics.
First instance decision on validity of EP 3 708 668 B1 (split poly-A tail technology) scheduled for March 25, 2025, by European Patent Office in the context of the German patent liti...
No comment yet